Lori Wood1, Georg A Bjarnason, Peter C Black, Ilias Cagiannos, Daniel Yick Chin Heng, Anil Kapoor, Christian K Kollmannsberger, Forough Mohammadzadeh, Ronald B Moore, Ricardo A Rendon, Denis Soulieres, Simon Tanguay, Peter Venner, Michael Jewett, Antonio Finelli. 1. Queen Elizabeth II Health Sciences Centre; Victoria General Hospital, Dalhousie University, Halifax, Nova Scotia; Sunnybrook Health Sciences Centre; St Michael's Hospital; Princess Margaret Hospital, University of Toronto, Toronto; University of Ottawa, Ottawa; St Joseph's Hospital, McMaster University, Hamilton, Ontario; Vancouver Prostate Centre, University of British Columbia; Vancouver Cancer Centre, University of British Columbia, Vancouver, British Columbia; Tom Baker Cancer Centre, Calgary; University of Alberta; Cross Cancer Institute, University of Alberta, Edmonton, Alberta; Centre Hospitalier de L'Université de Montreal, University of Montreal; and Montreal General Hospital, McGill University, Montreal, Quebec, Canada.
Abstract
PURPOSE: Optimal quality of care is needed for ideal outcomes. In renal cell carcinoma (RCC), there is a lack of information defining optimal care. This is particularly important in RCC, with increased complexity of care and a need for coordination among providers. The goal of this study was to identify quality indicators (QIs) and measures of quality care across the RCC disease spectrum. MATERIALS AND METHODS: A modified Delphi technique was used to select QIs that are relevant and practical to RCC care. This technique involved an expert panel of 13 urologic and medical oncologists who participated in two e-mail questionnaires and an in-person meeting to review and prioritize potential QIs. These potential QIs were identified from a systematic literature review or were suggested by panel members. RESULTS: From 233 literature citations, 34 possible QIs were identified; 24 additional potential QIs were suggested. A final set of 23 QIs was established. These are distributed across the RCC disease spectrum as follows (number of QIs in parentheses): screening (n=1), diagnosis/prognosis (n=3), surgical for localized disease (n=6), surgery for advanced disease (n=3), systemic therapy (n=6), and follow-up (n=2). In addition, two QIs related to survival outcomes (overall and progression-free survival) were selected. CONCLUSION: A systematic, consensus-based approach was used to determine relevant QIs in RCC care. These 23 QIs will provide a means of evaluating the quality of RCC care in an effort to improve outcomes in patients. The next step will be to establish a means of measuring each QI based on defined or yet-to-be-defined benchmarks.
PURPOSE: Optimal quality of care is needed for ideal outcomes. In renal cell carcinoma (RCC), there is a lack of information defining optimal care. This is particularly important in RCC, with increased complexity of care and a need for coordination among providers. The goal of this study was to identify quality indicators (QIs) and measures of quality care across the RCC disease spectrum. MATERIALS AND METHODS: A modified Delphi technique was used to select QIs that are relevant and practical to RCC care. This technique involved an expert panel of 13 urologic and medical oncologists who participated in two e-mail questionnaires and an in-person meeting to review and prioritize potential QIs. These potential QIs were identified from a systematic literature review or were suggested by panel members. RESULTS: From 233 literature citations, 34 possible QIs were identified; 24 additional potential QIs were suggested. A final set of 23 QIs was established. These are distributed across the RCC disease spectrum as follows (number of QIs in parentheses): screening (n=1), diagnosis/prognosis (n=3), surgical for localized disease (n=6), surgery for advanced disease (n=3), systemic therapy (n=6), and follow-up (n=2). In addition, two QIs related to survival outcomes (overall and progression-free survival) were selected. CONCLUSION: A systematic, consensus-based approach was used to determine relevant QIs in RCC care. These 23 QIs will provide a means of evaluating the quality of RCC care in an effort to improve outcomes in patients. The next step will be to establish a means of measuring each QI based on defined or yet-to-be-defined benchmarks.
Authors: Keith A Lawson; Olli Saarela; Zhihui Liu; Luke T Lavallée; Rodney H Breau; Lori Wood; Michael A S Jewett; Anil Kapoor; Simon Tanguay; Ronald B Moore; Ricardo Rendon; Frederic Pouliot; Peter C Black; Jun Kawakami; Darrel Drachenberg; Antonio Finelli Journal: Can Urol Assoc J Date: 2017-08 Impact factor: 1.862
Authors: Luke T Lavallée; Simon Tanguay; Michael A Jewett; Lori Wood; Anil Kapoor; Ricardo A Rendon; Ronald B Moore; Louis Lacombe; Jun Kawakami; Stephen E Pautler; Darrel E Drachenberg; Peter C Black; Jean-Baptiste Lattouf; Christopher Morash; Ilias Cagiannos; Zhihui Liu; Rodney H Breau Journal: Can Urol Assoc J Date: 2015 Mar-Apr Impact factor: 1.862
Authors: Misa Matsuyama; Mythily Sachchithananthan; Robyn Leonard; Michael Besser; Anna K Nowak; Donna Truran; Claire M Vajdic; John R Zalcberg; Hui K Gan; Craig Gedye; Winny Varikatt; Eng-Siew Koh; Ganessan Kichenadasse; Hao-Wen Sim; Nicholas G Gottardo; Desma Spyridopoulos; Rosalind L Jeffree Journal: Neurooncol Pract Date: 2021-08-31
Authors: Kristina Stojkov; Tobias Silzle; Georg Stussi; David Schwappach; Juerg Bernhard; David Bowen; Jaroslav Čermák; Avinash G Dinmohamed; Corien Eeltink; Sabrina Eggmann; Pierre Fenaux; Ulrich Germing; Manuel Haschke; Eva Hellstrom-Lindberg; Monika Heger; Arjan A van de Loosdrecht; Jakob Passweg; Michael Pfeilstöcker; Uwe Platzbecker; Luca Malcovati; António Medina de Almeida; Moshe Mittelman; Christine Morgenthaler; David P Steensma; Valeria Santini; Reinhard Stauder; Argiris Symeonidis; Sämi Schär; Charlotte Maddox; Theo de Witte; Julia Bohlius; Nicolas Bonadies Journal: Blood Adv Date: 2020-08-25
Authors: Abraham S Kanate; Ambuj Kumar; Peter Dreger; Martin Dreyling; Steven Le Gouill; Paolo Corradini; Chris Bredeson; Timothy S Fenske; Sonali M Smith; Anna Sureda; Alison Moskowitz; Jonathan W Friedberg; David J Inwards; Alex F Herrera; Mohamed A Kharfan-Dabaja; Nishitha Reddy; Silvia Montoto; Stephen P Robinson; Syed A Abutalib; Christian Gisselbrecht; Julie Vose; Ajay Gopal; Mazyar Shadman; Miguel-Angel Perales; Paul Carpenter; Bipin N Savani; Mehdi Hamadani Journal: JAMA Oncol Date: 2019-05-01 Impact factor: 31.777
Authors: Nicole Fortier O'Brien; Karin Reuter-Rice; Mark S Wainwright; Summer L Kaplan; Brian Appavu; Jennifer C Erklauer; Suman Ghosh; Matthew Kirschen; Brandi Kozak; Karen Lidsky; Marlina Elizabeth Lovett; Amy R Mehollin-Ray; Darryl K Miles; Craig A Press; Dennis W Simon; Robert C Tasker; Kerri Lynn LaRovere Journal: J Pediatr Intensive Care Date: 2020-09-04
Authors: Breda H Eubank; Nicholas G Mohtadi; Mark R Lafave; J Preston Wiley; Aaron J Bois; Richard S Boorman; David M Sheps Journal: BMC Med Res Methodol Date: 2016-05-20 Impact factor: 4.615